早产儿视网膜病变管理中的演变概念
本文为文献综述,总结早产儿视网膜病变(ROP)诊疗管理的演变概念。文章指出对1型或阈值前病变早期治疗可减少不良视觉和结构结局,抗血管内皮生长因子(VEGF)治疗在1型ROP中的作用近年内成为焦点,但疾病复发迁延及未知的眼部和全身不良反应引起部分临床医生担忧;远程医疗可能有助于筛查缺乏ROP诊疗人员的偏远地区。
要点
- 对1型或阈值前ROP进行早期治疗可减少不良视觉和结构结局。
- 抗VEGF治疗在1型ROP中的作用近年内成为焦点,但疾病复发迁延和未知的眼部及全身不良反应引起部分临床医生担忧。
- 远程医疗技术可能有助于筛查缺乏ROP诊疗人员的偏远地区,从而减轻疾病负担。
核心结论
- 过去40年ROP的诊断和管理已发生变化,抗VEGF治疗在当前治疗策略中的作用仍待确立。
- 初始疾病的筛查和进展监测可能受到远程医疗日益普及和临床医生相对短缺的影响。
研究设计与样本
- 文献综述,旨在综合ROP诊断和治疗不断演变的管理概念,并对当前新兴治疗提供解读和观点。
主要发现
- 初始治疗策略聚焦于阈值ROP的消融治疗,但已发现对1型或阈值前病变进行早期治疗可减少不良视觉和结构结局。
- 使用远程医疗技术可能提供筛查ROP诊疗人员短缺的偏远地区的能力,从而减轻疾病负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The introduction of anti-vascular endothelial growth factor (VEGF) agents has stimulated considerable reexamination of treatment strategies for the management of retinopathy of prematurity (ROP). Herein we summarize and review evolving concepts and provide a personal perspective on clinical management today and future directions of treatment. DESIGN: Literature review. METHODS: To synthesize the evolving management concepts for diagnosis and treatment of retinopathy of prematurity and to provide interpretation and perspective on current emerging therapies. RESULTS: Although initial treatment strategies focused on ablative therapy for threshold ROP, earlier treatment for type 1 or pre-threshold disease has been found to decrease unfavorable visual and structural outcomes. Vascular endothelial growth factor has emerged as a significant contributor to retinal-vascular diseases in the previous 2 decades. The potential role of anti-VEGF treatment for type 1 ROP has become a focus in recent years, but the protracted recurrence of disease and unknown adverse ocular and systemic effects have caused concern from some clinicians. In addition, the use of telemedicine technologies may provide the ability to screen remote areas with a shortage of ROP providers, thereby reducing the burden of disease. CONCLUSIONS: The diagnosis and management of ROP has changed over the past 40 years; the role of anti-VEGF therapy remains to be established in current treatment strategies. Screening for initial disease and progression will likely be impacted by the increasing prevalence of telemedicine and relative shortage of clinicians.
引用
- Sternberg P, Durrani AK. Evolving Concepts in the Management of Retinopathy of Prematurity. Am J Ophthalmol. 2017. PMID: 29109051. doi:10.1016/j.ajo.2017.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。